Incyte Corp INCY:NASDAQ

Last Price$85.12Cboe Previous Close - Real-Time Last Sale as of 4:00PM ET 4/06/20
Cboe Real-Time Quotes
Today's Change0(0.00%)
Bid (Size)$84.20 (300)
Ask (Size)$86.78 (44)
Day Low / HighN/A - N/A
Volume1.3 K
  • Latest Stories
  • Commentary and Analysis
Incyte Plans to Submit New Drug Application for Eczema Cream Following Phase Three Testing
1:48PM ET 4/06/2020 MT Newswires

Shares of Incyte (INCY) said on Monday that data from a study of its cream for eczema -- Atopic Dermatitis -- supports a plan for the company to submit a...

Sector Update: Health Care Stocks Outperform Broader Markets This Afternoon
3:59PM ET 4/03/2020 MT Newswires

Top Health Care Stocks JNJ -0.53% PFE +1.86% ABT -0.40% MRK -1.44% AMGN -2.25% Health care stocks continued their slide this afternoon, with the NYSE...

Sector Update: Negative Sentiment Dragging Health Care Stocks Lower
1:59PM ET 4/03/2020 MT Newswires

Top Health Care Stocks JNJ -0.41% PFE +1.79% ABT -0.60% MRK -0.94% AMGN -2.05% Health care stocks were falling, with the NYSE Health Care Index...

Sector Update: Health Care
1:19PM ET 4/03/2020 MT Newswires

Health care stocks were falling, with the NYSE Health Care Index declining 1% while the SPDR Health Care Select Sector ETF was down 1.3%. The Nasdaq...

MT Newswires After-Hours News Movers
5:43PM ET 4/02/2020 MT Newswires

Some of the stocks moving on news-driven events in Thursday's after-hours include: ECOR, +71.47% TSLA, +18.47% PLAY, +6.97% ZUMZ, +5.03% INCY, +3.80%...

Incyte to Start Late-Stage Trial of Ruxolitinib as Treatment for COVID-19 Associated Cytokine Storm
5:14PM ET 4/02/2020 MT Newswires

Incyte (INCY), a US biopharmaceutical company, said after markets closed on Thursday that it will start a late-stage clinical trial of ruxolitinib as a...

2020 and Q1 Estimates for Incyte Scaled Up but 2021 Earnings Number Falls
5:40AM ET 4/02/2020 MT Newswires

Consensus estimates for Incyte Corp's (NASDAQ:INCY, Recent Price: 74.18) Q1 ending March 31, 2020, and the full year forecasts for 2020 and 2021 have been...

--Analyst Actions: Morgan Stanley Upgrades Incyte to Overweight From Equal Weight, Lifts PT to $90 From $83
10:13AM ET 4/01/2020 MT Newswires

Price: 72.59, Change: -0.64, Percent Change: -0.87 ...

2020, 2021, and Q1 Earnings Estimates for Incyte Trimmed
1:55AM ET 3/26/2020 MT Newswires

Incyte Corp's (NASDAQ:INCY, Recent Price: 67.43) forecasted earnings estimates for Q1 ending March 31, 2020, and the expectations for 2020 and 2021 have...

--Analyst Actions: Oppenheimer Cuts Incyte's PT to $85 From $99 as COVID-19 Interrupts Office Visits, New Prescriptions; Outperform Rating Kept
10:21AM ET 3/25/2020 MT Newswires

Price: 68.04, Change: +0.61, Percent Change: +0.90 ...